TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33307277

Group type: EXPERIMENTAL
Intervention: Tiotropium added to inhaled corticosteroids and long-acting beta-agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium for frequent short-acting beta-agonist users
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiotropium for frequent exacerbators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled corticosteroids and long-acting beta-agonists (control group)
Number of subjects: 0
Study: 34040056

Group type: EXPERIMENTAL
Intervention: Simulation-based training (HelpMeSee Eye Surgery Simulator)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 0
Study: 35608433

Group type: EXPERIMENTAL
Intervention: Dezocine (0.1 mg/kg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (0.5 mg/kg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (0.5 mg/kg) combined with Dezocine (0.1 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 100
Study: 33637066

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and bupivacaine (ITMB) - 0.2 mg morphine and 7.5 mg bupivacaine (total 1.7 mL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and bupivacaine (ITMB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-ITMB (control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (ITMB and non-ITMB)
Number of subjects: 50
Study: 34717968

Group type: EXPERIMENTAL
Intervention: 5% menthol gel (Biofreeze™)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 15
Study: 34329606

Group type: COMPARATOR
Intervention: Vincristine (1.5 mg/m2) plus dexamethasone (6 mg/m2 per day for 7 days) during the second year of treatment (Control group)
Number of subjects: 5054

Group type: EXPERIMENTAL
Intervention: No vincristine and dexamethasone pulses during the second year of treatment (Experimental group)
Number of subjects: 5054

Group type: COMPARATOR
Intervention: Control group (Vincristine and dexamethasone)
Number of subjects: 5054

Group type: EXPERIMENTAL
Intervention: Experimental group (No vincristine and dexamethasone)
Number of subjects: 5054
Study: 32073152

Group type: EXPERIMENTAL
Intervention: Family-based prevention program (ProSAAF)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 298
Study: 35918962

Group type: EXPERIMENTAL
Intervention: Lupin's biosimilar ranibizumab
Number of subjects: 202

Group type: COMPARATOR
Intervention: Lucentis®
Number of subjects: 202
Study: 33380602

Group type: EXPERIMENTAL
Intervention: Shared Medical Appointments (SMAs)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 23
Study: 34282619

Group type: EXPERIMENTAL
Intervention: Cementless short stem Metha
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cementless conventional straight stem Bicontact (control)
Number of subjects: 50
Study: 34501792

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise program (12 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual lifestyles (Control Group)
Number of subjects: 64
Study: 33000589

Group type: EXPERIMENTAL
Intervention: Xinkeshu combined with levosimendan
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (levosimendan only)
Number of subjects: 100
Study: 35805620

Group type: EXPERIMENTAL
Intervention: 2.4 g per day WNS
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4.8 g per day WNS
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 33818599

Group type: EXPERIMENTAL
Intervention: Detention in a juvenile justice facility
Number of subjects: 1829
Study: 32604235

Group type: EXPERIMENTAL
Intervention: Picosecond laser
Number of subjects: 14

Group type: COMPARATOR
Intervention: Q‐switched laser
Number of subjects: 14
Study: 35627475

Group type: EXPERIMENTAL
Intervention: L-arginine supplementation
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Beetroot supplementation
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: L-citrulline supplementation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 33736915

Group type: EXPERIMENTAL
Intervention: One dose of measles-mumps-rubella and one dose of varicella vaccine
Number of subjects: 5803

Group type: EXPERIMENTAL
Intervention: Two doses of measles-mumps-rubella-varicella vaccine
Number of subjects: 5803

Group type: COMPARATOR
Intervention: Control group (two doses of measles-mumps-rubella vaccine)
Number of subjects: 5803

Group type: EXPERIMENTAL
Intervention: Both one-dose and two-dose varicella-containing vaccines
Number of subjects: 5803

Group type: EXPERIMENTAL
Intervention: Increasing varicella-specific antibody concentrations
Number of subjects: 5803
Study: 34518906

Group type: EXPERIMENTAL
Intervention: Peritonsillar injection of bupivacaine (0.1 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous acetaminophen (12.5 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peritonsillar injection of bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous acetaminophen
Number of subjects: 60
Study: 33418204

Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35711582

Group type: EXPERIMENTAL
Intervention: Mindfulness‐integrated Cognitive Behavior Therapy (MiCBT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 125
Study: 34556414

Group type: EXPERIMENTAL
Intervention: Vitrification with microinjection of single seminiferous tubules (VLP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vitrification without microinjection
Number of subjects: 10

Group type: COMPARATOR
Intervention: Uncontrolled slow freezing (USF)
Number of subjects: 10
Study: 35988289

Group type: EXPERIMENTAL
Intervention: Continuous blood purification treatment (hemofiltration without heparin followed by hemoadsorption)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard sepsis care (Control group)
Number of subjects: 100
Study: 32877581

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (weekly sessions for 6 months, monthly sessions for 18 months)
Number of subjects: 803

Group type: COMPARATOR
Intervention: Usual care (standard care from primary care team)
Number of subjects: 803
Study: 35018452

Group type: EXPERIMENTAL
Intervention: Working memory training (up to 15 sessions)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 177
Study: 34269550

Group type: COMPARATOR
Intervention: Placebo-controlled intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized double-blinded studies
Number of subjects: 0
Study: 33112249

Group type: EXPERIMENTAL
Intervention: iSpy app
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study: 35366488

Group type: EXPERIMENTAL
Intervention: Pet therapy program
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard training (control group)
Number of subjects: 44
Study: 33097941

Group type: COMPARATOR
Intervention: Vitamin-D therapy
Number of subjects: 0
Study: 33015927

Group type: EXPERIMENTAL
Intervention: INFOSA‐DEM intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35710510

Group type: EXPERIMENTAL
Intervention: Neck isometric exercises
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conservative management without exercise
Number of subjects: 24
Study: 34205413

Group type: EXPERIMENTAL
Intervention: Acarbose for four weeks
Number of subjects: 18
Study: 35013789

Group type: EXPERIMENTAL
Intervention: Lemon juice
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tea
Number of subjects: 10
Study: 33476532

Group type: EXPERIMENTAL
Intervention: Direct weaning from HFOV (Observation group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation after HFOV (Control group)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 101
Study: 34343424

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 µg once daily for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo once daily for 6 months
Number of subjects: 30
Study: 35180298

Group type: EXPERIMENTAL
Intervention: Acetaminophen (500 mg or 1000 mg every 6 hours for 72 hours)
Number of subjects: 396

Group type: COMPARATOR
Intervention: No acetaminophen (Control)
Number of subjects: 396
Study: 34278874

Group type: EXPERIMENTAL
Intervention: Lorazepam 0.5 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg
Number of subjects: 50
Study: 32275364

Group type: EXPERIMENTAL
Intervention: Dilatational wave electroacupuncture (frequency of 2 Hz/10 Hz)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Continuous wave electroacupuncture (frequency of 10 Hz)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Discontinuous wave electroacupuncture (frequency of 10 Hz)
Number of subjects: 97
Study: 35703814

Group type: EXPERIMENTAL
Intervention: Robotic repair
Number of subjects: 75

Group type: COMPARATOR
Intervention: Laparoscopic repair
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 75
Study: 33789574

Group type: EXPERIMENTAL
Intervention: Colistin-meropenem combination therapy
Number of subjects: 701

Group type: COMPARATOR
Intervention: Colistin monotherapy
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Colistin treatment duration
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 701
Study: 32032540

Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes
Number of subjects: 5028

Group type: COMPARATOR
Intervention: Type 2 diabetes
Number of subjects: 5028

Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes (first 9 years)
Number of subjects: 5028

Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes (subsequent years)
Number of subjects: 5028

Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes (after correcting for HbA1c)
Number of subjects: 5028
Study: 35299132

Group type: EXPERIMENTAL
Intervention: Trainee group
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Current staff
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Negative perceptions of morality
Number of subjects: 258
Study: 33789556

Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34057129

Group type: EXPERIMENTAL
Intervention: Passive ankle dorsiflexion intervention (real)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham passive ankle dorsiflexion intervention (control)
Number of subjects: 73
Study: 33947349

Group type: EXPERIMENTAL
Intervention: Orally administrated misoprostol (Cytotec®)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Misoprostol vaginal insert (Misodel®)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Severe fear of childbirth (W‐DEQ A score ≥ 85)
Number of subjects: 196
Study: 32227179

Group type: EXPERIMENTAL
Intervention: Comfort AD
Number of subjects: 492

Group type: COMPARATOR
Intervention: Standard AD
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Life-extending AD
Number of subjects: 492
Study: 35388038

Group type: EXPERIMENTAL
Intervention: Psychological insight‐oriented therapy (IOT) - five 1‐h sessions
Number of subjects: 47

Group type: COMPARATOR
Intervention: Disease related education (ED) - five 1‐h sessions
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Psychological insight‐oriented therapy (IOT) - first intervention
Number of subjects: 47

Group type: COMPARATOR
Intervention: Disease related education (ED) - first intervention
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both interventions (IOT and ED)
Number of subjects: 47
Study: 32178221

Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 266
Study: 33727460

Group type: EXPERIMENTAL
Intervention: Peribulbar block (Group PB)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Topical anesthesia (Group TA)
Number of subjects: 106
Study: 33093056

Group type: EXPERIMENTAL
Intervention: Convalescent plasma with best standard of care
Number of subjects: 464

Group type: COMPARATOR
Intervention: Best standard of care only
Number of subjects: 464
Study: 34118367

Group type: EXPERIMENTAL
Intervention: CVs from men
Number of subjects: 0

Group type: COMPARATOR
Intervention: CVs from women
Number of subjects: 0
Study: 32706933

Group type: EXPERIMENTAL
Intervention: 10-week Inspired Life Program (ILP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study: 34227246

Group type: EXPERIMENTAL
Intervention: Computerized Progressive Attentional Training (CPAT), n=14, 2 sessions per week for 2 months.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Active control group, n=12, matched at baseline.
Number of subjects: 26
Study: 32502105

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal cannula
Number of subjects: 26

Group type: COMPARATOR
Intervention: No nasopharyngeal cannula
Number of subjects: 26
Study: 35482079

Group type: EXPERIMENTAL
Intervention: DM-INI
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Control-INI
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Overall INI effect (combined DM-INI and Control-INI cohort)
Number of subjects: 244

Group type: COMPARATOR
Intervention: INI
Number of subjects: 244
Study: 34333191

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity intervention (asthma education, Fitbit, monthly group sessions, text messages, individual step goals, and study manual)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) (asthma education plus Fitbit)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 53
Study: 35061236

Group type: EXPERIMENTAL
Intervention: DS-1040 (0.6, 1.2, 2.4 or 4.8 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 34964167

Group type: EXPERIMENTAL
Intervention: Two-step irradiance group (40 mW/cm2 for 8 min followed by 80 mW/cm2 for 16 min)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (80 mW/cm2 for 20 min)
Number of subjects: 127
Study: 33533688

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC) for 2.5 hours/day during NICU hospitalization
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 79
Study: 32114377

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (12-15 sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 35906640

Group type: EXPERIMENTAL
Intervention: Soy isoflavones (50 mg per day for 8 weeks)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 34801045

Group type: EXPERIMENTAL
Intervention: Checklist-based box system intervention
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: Institutional delivery
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: Knowledge on danger signs during postnatal period
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Influence by older generations
Number of subjects: 1162
Study: 35446596

Group type: EXPERIMENTAL
Intervention: Fluid (DRINK)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Semisolid gel (GEL)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Solid jelly chew (CHEW)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Coingestion (MIX)
Number of subjects: 9
Study: 33764613

Group type: EXPERIMENTAL
Intervention: Intradermal injection of plasma gel combined with fractional CO2 laser
Number of subjects: 36

Group type: COMPARATOR
Intervention: Fractional CO2 laser alone (saline as placebo)
Number of subjects: 36
Study: 32191142

Group type: EXPERIMENTAL
Intervention: PROMISE breastfeeding protocol (1077BF)
Number of subjects: 3847

Group type: EXPERIMENTAL
Intervention: PROMISE formula-feeding protocol (1077FF)
Number of subjects: 3847

Group type: EXPERIMENTAL
Intervention: Late Presenters
Number of subjects: 3847

Group type: EXPERIMENTAL
Intervention: Overall study preparation and collaboration
Number of subjects: 3847
Study: 35044802

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy alone (MED)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incremental cost-effectiveness ratio for CABG compared with MED
Number of subjects: 0
Study: 33259734

Group type: EXPERIMENTAL
Intervention: Yugengtongyu granules
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 33287711

Group type: EXPERIMENTAL
Intervention: CerebAir® EEG headset positioned by ICU physician
Number of subjects: 40

Group type: COMPARATOR
Intervention: Simplified 8-electrodes-EEG recording positioned by EEG technician
Number of subjects: 40
Study: 34488856

Group type: EXPERIMENTAL
Intervention: Pain neuroscience education + craniocervical manual therapy and exercises
Number of subjects: 148

Group type: COMPARATOR
Intervention: Craniocervical manual therapy and exercises
Number of subjects: 148
Study: 35094487

Group type: EXPERIMENTAL
Intervention: Self-expanding transcatheter aortic valve replacement (TAVR)
Number of subjects: 27
Study: 35190085

Group type: EXPERIMENTAL
Intervention: Gufoni maneuver
Number of subjects: 48

Group type: COMPARATOR
Intervention: Barbecue roll maneuver
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Gufoni-Appiani maneuver
Number of subjects: 48

Group type: COMPARATOR
Intervention: Zuma-e-Maia maneuver
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Single maneuver
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Multiple maneuvers (up to 4)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Follow-up after one week
Number of subjects: 48
Study: 33043411

Group type: EXPERIMENTAL
Intervention: Digitally-enhanced 16-week social support pilot intervention including telephone counseling calls and Jawbone UP activity monitor.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Digitally-enhanced 16-week social support pilot intervention.
Number of subjects: 30
Study: 35780488

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 111

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 111
Study: 34221076

Group type: EXPERIMENTAL
Intervention: Yoga exercises for 6 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 61
Study: 32618538

Group type: EXPERIMENTAL
Intervention: Childhood obesity prevention intervention group with nutrition education at family nights for parents and at school for children.
Number of subjects: 316

Group type: COMPARATOR
Intervention: Comparison group (parent workshops unrelated to nutrition).
Number of subjects: 316
Study: 35753838

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of EV71 vaccine and MR vaccine
Number of subjects: 680

Group type: COMPARATOR
Intervention: Separate administration of EV71 vaccine
Number of subjects: 680

Group type: COMPARATOR
Intervention: Separate administration of MR vaccine
Number of subjects: 680
Study: 34389016

Group type: EXPERIMENTAL
Intervention: With drainage
Number of subjects: 100

Group type: COMPARATOR
Intervention: Without drainage
Number of subjects: 100
Study: 34062084

Group type: EXPERIMENTAL
Intervention: Overlapping symptoms
Number of subjects: 4403

Group type: COMPARATOR
Intervention: GERS only
Number of subjects: 4403

Group type: COMPARATOR
Intervention: Dyspepsia only
Number of subjects: 4403
Study: 32072685

Group type: EXPERIMENTAL
Intervention: ACB + ABB (20% autogenous cortical bone and 80% anorganic bovine bone)
Number of subjects: 8

Group type: COMPARATOR
Intervention: ACB + BP (20% autogenous cortical bone and 80% modified biphasic phycogenic material)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ACB + ABB
Number of subjects: 8

Group type: COMPARATOR
Intervention: ACB + BP
Number of subjects: 8
Study: 35367986

Group type: EXPERIMENTAL
Intervention: Internet-delivered transdiagnostic psychological intervention
Number of subjects: 676

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 676
Study: 33972248

Group type: COMPARATOR
Intervention: Standard oral dose (10 mg/kg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: High-dose oral (35 mg/kg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intravenous (20 mg/kg)
Number of subjects: 46
Study: 32762272

Group type: EXPERIMENTAL
Intervention: 600 mg oral CBD
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 34714144

Group type: EXPERIMENTAL
Intervention: Walnut Snack (WS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Gummy Snack (GS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No Snack (NS; control)
Number of subjects: 36
Study: 34052004

Group type: EXPERIMENTAL
Intervention: Transfusion of adult-derived donor packed red blood cell (pRBC) units, n=9
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Transfusion of adult-derived donor packed red blood cell (pRBC) units, n=5
Number of subjects: 16

Group type: COMPARATOR
Intervention: No transfusion, n=85 samples
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (non-transfused patients), n=25
Number of subjects: 16
Study: 33142450

Group type: EXPERIMENTAL
Intervention: Selenium-enriched earthworm powder (SEP) 1.0 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Selenium-enriched earthworm powder (SEP) 0.5 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Earthworm powder alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (0 mg/kg Se)
Number of subjects: 120
Study: 33075842

Group type: EXPERIMENTAL
Intervention: Logistic regression model developed based on training set (n = 9,739) including maternal age, body mass index (BMI), cervical dilatation, and gestational age on admission.
Number of subjects: 19611

Group type: EXPERIMENTAL
Intervention: Logistic regression model predictions based on a subset of 18,803 patients.
Number of subjects: 19611
Study: 34817388

Group type: EXPERIMENTAL
Intervention: Intervention app 'Not Less But Better' for 20 days with five 4-day training modules.
Number of subjects: 232

Group type: COMPARATOR
Intervention: Active control condition (digital detox treatment).
Number of subjects: 232